Plain-English translation of NCT07144319 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is collecting video and image data from bladder cancer screening procedures called blue light cystoscopy—a procedure where doctors use a special camera and fluorescent dye to look inside the bladder for cancerous lesions. The goal is to gather this information to train an artificial intelligence (AI) computer system to automatically detect bladder cancer during these exams, which could help doctors catch more cancers and reduce human error.
Currently, doctors visually examine the bladder during these procedures, which can be subjective and varies depending on the physician's experience. This medication helps highlight cancer cells under blue light, but the decision of what to biopsy still depends on the doctor's judgment. By training AI on many real-world exam recordings, researchers hope to create a system that can automatically spot suspicious lesions in real time and help physicians make better decisions.
You likely qualify if…
You likely don't qualify if…
If you join, your participation is simple: you will have your blue light cystoscopy procedure performed as usual as part of your regular medical care, and the doctors will record video and take images during that exam. Your clinical information will also be collected. The study is purely observational—you are not receiving any new treatment or medication, just allowing your routine procedure to be documented and used to train the AI system.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
Norway